Introduction
MHC II molecules present foreign antigens to T h cells and human and murine CIITA proteins (6) , this mutant CIITA protein is found in the cytoplasm and has no activity (4) . direct the subsequent differentiation of B cells. Their congenital absence leads to a severe combined immunodeficiency In the conserved upstream sequences (CUS) of MHC II promoters, RFX recognizes S and X boxes (7) . Other proteins, called the type II bare lymphocyte syndrome (BLS) (1). Using B lymphoblastoid cell lines and transient heterokaryon fusions, which include the cAMP responsive element binding protein (CREB), nuclear factor Y (NF-Y: NF-YA, -YB and -YC) and five complementation groups (A-E) of BLS were characterized. Whereas group E appears to affect a locus organizing octamer binding factor, bind to the downstream X2, Y and octamer sequences (8, 9) . They are critical for IFN-γ-inducible region (2), the expression of all MHC II genes is extinguished in groups A-D. They contain mutations in genes that code and constitutive expression of MHC II genes. CIITA neither binds directly to DNA nor appears in electrophoretic mobility for the class II transactivator (CIITA) and regulatory factor that binds to the X box (RFX), which is composed of three shift assays (EMSA) with proteins assembled on CUS (3). Nevertheless, subunits of RFX, NF-Y and CREB have been subunits, RFX-5, RFX-AP and RFX-ANK/B. In BLS-2 cells (group A), the CIITA gene has a short in-frame deletion which reported to bind to CIITA in cells (10) (11) (12) . In one report, this binding depended on p33, which is an unknown protein that includes one of its nuclear localization signals (NLS) from positions 940 to 963 (3, 4) . Although CIITA contains an addibinds to the C-terminal leucine-rich repeats of CIITA (13) . CIITA attracts several transcription factors to its N-terminal tional putative bipartite nuclear targeting sequence from positions 144 to 161 (5), both of which are conserved between activation domain. These include the TATA-box binding protein associated factors TAFII32 and TAFII70, histone acetyltransgift from J. P.-Y. Ting), p∆CAN (a gift from B. Cullen) and NF-AT-luciferase reporter gene have been described previferase CREB binding protein (CBP/p300) and cyclin T1, which forms the positive transcription elongation factor b (P-TEFb) ously (18, 22, 26, 28) . (14) (15) (16) (17) (18) (19) (20) (5, (21) (22) (23) (24) (25) . To date, the best is a truncated CIITA protein, p∆CAN or stuffer DNA (0.25-1.5 µg) in COS cells by lipofectawhich lacks the N-terminal acidic and P/S/T-rich sequences mine (Life Technologies, Germantown, MD). COS cells (23) . However, this dominant-negative CIITA protein could not (2ϫ10 5 ) were incubated with 6 µl of lipofectamine with DNAs extinguish the expression of MHC II genes (23) . Moreover, for 16 h. Cells were harvested and extracted with 200 µl of its mechanism of action remained unexplained. Also, the lysis buffer (0.25 M Tris-HCl, pH 7.5, 0.1% Triton X-100) 24 h dominant-negative forms of CBP (DNCBP) and CDK9 after transfection. Lysates were inactivated at 65°C for 10 min, (DNCDK9 from P-TEFb) block the function of CIITA (15, 18 5 ) were cultured for 24 h and then the cells were with 10% FCS and antibiotics (100 U/ml of penicillin G/100 incubated with human IFN-γ (1000 U/ml; Boehringer µg/ml of streptomycine sulfate) at 37°C in 5% CO 2 . Jurkat Mannheim, Indianapolis, IN) for 72 h. HeLa cells were harand RM3 cells were grown in RPMI 1640 supplemented with vested and stained with appropriate antibodies, and then 10% FCS and antibiotics described above at 37°C in 5% CO 2 .
analyzed by FACS (Becton Dickinson, San Jose, CA).
Plasmids and the constructs
Electroporation and superantigen assay Either wild-type CIITA (amino acids 1-1130) or dCIITA (amino RM3 cells (1ϫ10 7 ) were transfected with pCIITA (20 µg) and acids 302-1130 ) genes were fused with EGFP using pEGFPeither pEdCIITA or the empty plasmid DNA (20 µg each) by C1 vector (Clontech, Palo Alto, CA), termed pECIITA and electroporation as described above. The cells were harvested pEdCIITA respectively. Also, HA-tagged wild-type CIITA and 48 h after transfection and stained with appropriate antibodies dCIITA was subcloned into the same backbone vector as a for FACS analyses. For superantigen assay, the electroporcontrol, termed pCIITA and pdCIITA respectively. The HA-tag ation was performed 48 h prior to co-culture. On the other sequence, 5Ј-TACCCATACGATGTTCCAGATTACGCTGCT-3Ј, hand, NF-AT-luciferase reporter gene (40 µg) was transfected was inserted after first ATG of the N-terminus of CIITA cDNA in Jurkat cells (1ϫ10 7 ) by electroporation 24 h prior to coin pCIITA and pECIITA. HA-tagged CIITA has similar activity culture. The transfected Jurkat cells were cultured with either with wild-type CIITA in the CAT assay (J. D. Fontes and B. M.
the transfected or untransfected RM3 in the presence or Peterlin, unpublished data). All plasmids were regulated under absence of Staphylococcal enterotoxin D (SED; Toxin the cytomegalovirus promoter. All plasmid constructs were Technology, Sarasota, FL) for 16 h. Cells were lysed and sequenced and their expressions confirmed by Western blotluciferase assays were performed as described previously ting. The reporter gene, pDRASCAT, contains the DRA (18). promoter linked with the CAT gene, which have been previ-FACS analyses ously described (27). The empty plasmid vector was used as a stuffer DNA in all experiments. Plasmids coding for Tat, Both transfected HeLa cells and RM3 cells were stained with anti-DR (clone L243), -DQ (clone SK10) or -DP (clone B7/21) DNCDK9, DNp300 (a gift from K. Kelly), pcDNA3flagCIITA (a CBP and cyclin T1 from P-TEFb bind to the N-terminus of CIITA (positions 1-144 and 1-322 respectively). DNCDK9 contains an asparagines rather than aspartic acid at position 167, which inactivates the kinase activity of CDK9. DNp300 contains residues from positions 1514 to 1922 in p300, which blocks histone acetyltransferase activity. antibodies in PBS with 5% BSA/0.1% sodium azide for 20 min.
only CIITA was co-expressed with the plasmid target (%). CAT Secondary staining was performed with phycoerythrin-conjugenzymatic assays were performed as described previously (27). Data represent the inhibition of EdCIITA (s) and dCIITA (m) respectively. ated rat anti-mouse κ antibody (clone X36) (all antibodies Error bars give SEM from three experiments performed in duplicate.
were purchased from Becton Dickinson, Mountain View, CA).
Below the graph are presented expression levels of EdCIITA, dCIITA
The expressions of MHC II proteins and EdCIITA were anaand actin, which were determined by Western blotting. Lysates were lyzed by FACS.
immunoprecipitated with the rabbit polyclonal anti-CIITA antibody and then blotted with the same antibody. Levels of actin were determined with an anti-actin antiserum.
Results

EdCIITA prevents the activation of the DRA promoter by CIITA
To create an optimal dominant-negative CIITA protein, we relied on previously published work (5, (21) (22) (23) (24) (25) . dCIITA lacks for each combination of plasmids. At a 1:1 molar ratio of cotransfected plasmids, EdCIITA repressed the DRA promoter the first 301 amino acids of CIITA, which include acidic (positions 26-137), bipartite nuclear targeting (positions 144-10-fold, and extinguished it to background levels at 1:3 and 1:6 molar ratios (Fig. 2, open circles) . dCIITA was much less 161) and P/S/T-rich sequences (positions 163-322) (Fig. 1) . The wild-type CIITA and dCIITA proteins were fused in-frame potent at these concentrations and never blocked the DRA promoter completely (Fig. 2, solid triangles) . Although only to the C-terminus of EGFP, and termed ECIITA and EdCIITA respectively. Next, we compared effects of these proteins on effects at 72 h are presented, identical results were obtained at shorter and longer times after transfection (data not prethe DRA promoter. dCIITA or EdCIITA were co-expressed with CIITA, and the plasmid target, pDRASCAT, in COS cells. All sented). EdCIITA could function better than dCIITA because of its different composition (the addition of EGFP), greater transcripts coding for our proteins were transcribed from the cytomegalovirus immediate-early promoter. The inhibition of stability or subcellular localization. We conclude that EdCIITA is a strong dominant-negative CIITA protein. Moreover, the DRA promoter was observed in a dose-dependent manner RM3 cells were established as a MHC II-deficient B cell line from Raji cells. However, the exogenous expression of CIITA in these cells leads to the synthesis of MHC II determinants because it is linked to EGFP, its levels of expression can be monitored easily in cells.
to levels that are comparable to those on parental Raji cells. We chose RM3 because of the slow decay of pre-existing
IFN-γ fails to induce the expression of MHC II genes in HeLa
MHC II-peptide complexes on Raji and other antigen-precells expressing EdCIITA senting cells. As presented in Fig. 4(B) , the introduction of CIITA restored high levels of expression of DR, DQ and DP The administration of IFN-γ activates the Jak/Stat signaling cascade and CIITA transcription (29, 30) . This induction is determinants on RM3 cells. In sharp contrast, CIITA failed to rescue the expression of MHC II determinants in the presence critical for the function of antigen-presenting cells. To confirm that EdCIITA could also block effects of IFN-γ, we expressed of EdCIITA (Fig. 4C ). This inhibition was from 9.8 to 0.9% of DR ϩ cells, 9.3 to 1.4% of DP ϩ cells and 4.0 to 0.4% of DQ ϩ EdCIITA for 2 days in HeLa cells, which were subsequently treated with 1000 U/ml of IFN-γ for 3 days. Cells were stained cells respectively (Fig. 4, cf. B and C). This inhibition was observed only in green fluorescent RM3 cells that expressed with the antibody against DP and then analyzed by FACS (Fig. 3) . The expression of EdCIITA was followed by green EdCIITA. These results were confirmed in RJ2.2.5 cells (data not presented). Thus, EdCIITA inhibits efficiently the expresfluorescence and was abundant in~30% of HeLa cells for the duration of the assay. In Fig. 3 , they are visualized on the sion of MHC II genes in B lymphoblastoid cells. x-axis (Fig. 3E, R2) . Cells in the R1 region did not express
EdCIITA blocks the presentation of superantigen by MHC II pEdCIITA and resembled untransfected cells (Fig. 3E) . Importdeterminants to T cells antly, the inhibition of DP was observed only in cells that expressed EdCIITA (Fig. 3, R2 ). These data were confirmed EdCIITA blocked the expression of MHC II genes in kidney cells (COS) that expressed CIITA, IFN-γ-treated epithelial cells with antibodies against DR determinants (data not presented).
Although mutant CIITA proteins lacking the C-terminal NLS and bearing mutations in GTP-binding domains are found in the cytoplasm, EdCIITA still contains both sequences. EdCIITA lacks only the putative N-terminal NLS (Fig. 1) . Thus, EdCIITA should still enter the nucleus. Additionally, CIITA contains many leucines, especially near its C-terminus, some of which are spaced in a manner reminiscent of nuclear export signals (NES). Thus, it is possible that EdCIITA enters the nucleus but is rapidly exported to the cytoplasm. In the steady state, EdCIITA would then appear cytoplasmic. To examine directly whether these shuttling mechanisms in EdCIITA functioned, we co-expressed the dominant-negative nucleoporin ∆CAN, which blocks the function of NES (26). Indeed, when EdCIITA was co-expressed with ∆CAN, EdCIITA was localized in the nucleus (Fig. 6E) . On the other hand, ECIITA and EGFP retained their previous subcellular distribution (Fig. 6D and  F) . We conclude that CIITA is a shuttling protein, that it Previously, we demonstrated that CIITA binds to CBP and cyclin T1 from P-TEFb to affect the chromatin conformation and elongation of transcription of MHC II genes. Dominantnegative forms of CBP or p300 (DNp300, Fig. 1 ) and CDK9 (HeLa) and B lymphoblastoid cells (RM3). Moreover, since Ii, DMA and DMB genes are also regulated by CIITA, EdCIITA from P-TEFb (kinase dead CDK9, CDK9N167N, DNCDK, Fig.  1 ) could inhibit MHC II transcription. Since Tat, which is an should block antigen processing and presentation. To examine functional consequences of this blockade, we studied essential transactivator of viral replication, bound to the same surface on cyclin T1 and blocked effects of CIITA, HIV-1 effects of EdCIITA on T cell activation via superantigen and MHC II determinants on B cells. The diagram of this experiment inhibits efficiently antigen processing and presentation by MHC II determinants. DNp300 and DNCDK9 are nuclear is presented in Fig. 5(A) . Again, RM3 cells expressed CIITA with or without EdCIITA. Transfected cells were co-cultured proteins that act at a post-assembly step, when DNA-bound proteins have already recruited CIITA. Thus, they should block with Jurkat cells, which contained the NF-AT-luciferase reporter gene, in the presence or absence of SED. MHC II the activity of the residual CIITA in B cells and antigenpresenting cells, and act synergistically with each other complex:superantigen induces T cell signaling via the TCR and activates the NF-AT reporter gene in Jurkat cells. The and EdCIITA. Indeed, Tat and both dominant-negative proteins potentiexpression of CIITA alone resulted in NF-AT activity only in the presence of SED (Fig. 5, lane 6) . On the other hand, ated effects of EdCIITA in COS cells. Tat, DNp300 and DNCDK9 alone inhibited CIITA function on the DRA promoter EdCIITA strongly inhibited our superantigen assay (Fig. 5,  lane 8) . Levels of inhibition correlated perfectly with the ( Fig. 7A, lanes 4, 6 and 8 ). They acted synergistically with small amounts of EdCIITA (Fig. 7A, lanes 5, 7 and 9 ). expression of MHC II genes and the inhibition of the DRA promoter (Fig. 2) . Similar results were obtained when a Moreover, the combination of EdCIITA, DNp300 and DNCDK9 extinguished the expression from the DRA promoter to backplasmid target containing the NF-κB binding sites linked to luciferase was used (data not presented). Thus, EdCIITA ground levels (Fig. 7B, lane 4) . All dominant proteins were expressed to equivalent levels in these cells (data not preblocks the expression and function of MHC II determinants.
sented). We conclude that EdCIITA, DNp300 and DNCDK9 Unlike CIITA, EdCIITA is localized in the cytoplasm act at different steps of MHC II transcription and thus synergistically to block the function of CIITA. It is thought that the dominant-negative CIITA proteins, such as dCIITA, compete with CIITA for the binding to MHC II promoters in the nucleus of cells. To check the validity of this Discussion model, we examined the distribution of EdCIITA in COS cells. As presented in Fig. 6(A) , ECIITA was found in the nucleus.
In this study we demonstrated that EdCIITA inhibits efficiently the function of CIITA. EdCIITA diminished the expression of In sharp contrast, EdCIITA was localized in the cytoplasm (Fig. 6B) . EGFP alone was distributed throughout the cell MHC II genes in HeLa cells, which were treated with IFN-γ, and in B lymphoblastoid RM3 cells. EdCIITA also inhibited (Fig. 6C) . This result suggests that EdCIITA acts indirectly to block the function of CIITA. One possibility is that it sequesters T cell activation by superantigen. Surprisingly, at steady state, whereas CIITA was localized in the nucleus, EdCIITA was a co-factor of CIITA in the cytoplasm. found in the cytoplasm. However, EdCIITA is a shuttling and RFX bind to DNA and to CIITA. However, this recruitment requires an additional protein of 33 kDa, which binds to the protein. ∆CAN blocked the export of EdCIITA from the nucleus, which suggested that EdCIITA sequesters some co-factor of leucine-rich repeats in CIITA and possibly other co-factors. These other cellular proteins might explain the dichotomy CIITA in the cytoplasm. DNp300, DNCDK9 or Tat inhibited the remaining CIITA in the nucleus. Since EdCIITA, DNp300, between binding studies of individual components (CREB, CIITA, NF-Y and RFX) in cells and the inability of CIITA alone DNCDK9 or Tat affect different steps in the transcription of MHC II genes, they acted synergistically. We conclude that to bind to these proteins in EMSA. Additionally, CIITA binds to general transcription factors and CBP to initiate MHC II combinatorial approaches might offer the best hope of extinguishing the expression of MHC II genes in cells and in the transcription. CIITA also binds to P-TEFb, which phosphorylates the C-terminal domain of RNA polymerase II to elongate organism.
This study used the most recent advances in our under-MHC II transcription. Our dominant-negative strategies attacked these different steps. standing of steps in the assembly and function of regulatory proteins on MHC II promoters. CREB, and subunits of NF-Y First, EdCIITA linked dCIITA to EGFP. The latter addition and DNCDK9 functioned synergistically with EdCIITA to extinguish the expression of MHC II genes. As expected, these proteins had to be added separately. A chimera between EdCIITA and DNp300, DNCDK9 or Tat alone or in combination functioned no better than EdCIITA alone. EdCIITA in the cytoplasm and DNp300 or DNCDK9 in the nucleus would then target most efficiently different cellular partners of CIITA. At these lower concentrations of separate components, we would also expect fewer deleterious effects on the transcription of other cellular genes. The model that emerges from this study is presented in Fig. 8 . Since effects of CBP and P-TEFb in MHC II transcription had already been diagrammed, only the sequestration of a critical co-factor for CIITA is depicted. In this scenario, CIITA is a shuttling protein that resides mostly in the nucleus. What circumstance would require its rapid removal from the nucleus via the NES is speculative, but could include aspects of innate immunity, sepsis or toxic shock. With the removal of the N-terminal activation domain and the addition of EGFP, EdCIITA is now a predominantly cytoplasmic protein. However, it transits the nucleus, where it could also compete for the binding to MHC II promoters and remove a critical cofactor from CIITA (protein X). This event might not only inhibit productive interactions between CIITA and MHC II promoters but also affect the communication between CIITA and the so that although EdCIITA transits the nucleus, it is exported efficiently into the cytoplasm. At steady state, most of EdCIITA is in the cytoplasm. Therefore, EdCIITA most likely sequesters a co-factor of
